Paper33734005
Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma.
Balakrishna J and 10 others. Leuk Lymphoma, 2021. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma. Papers, record 33734005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33734005
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma.
- PubMed
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leukemia, Lymphocytic, Chronic, B-Cell | Major topic |
| Lymphocytosis | Major topic |
| B-Lymphocytes | |
| Humans | |
| Immunoglobulin Heavy Chains | |
| Mutation | |
| Prognosis |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| ZIA HL006070 | Intramural NIH HHS | United States | ZIAHL006070 | PubMed | NIH RePORTER |
| ZIAHL002346 | NIH | NIH RePORTER | |||
| ZICBC011104 | NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00001620 | Screening for Hematology Branch Protocols | Derived from the trial | Yes |
Source ClinicalTrials.gov
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10477712 | Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. | Blood | 1999 | https://conductscience.org/library/papers/10477712 | PubMed |
| 2 | 28782884 | Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment. | Am J Hematol | 2017 | https://conductscience.org/library/papers/28782884 | PubMed |
| 3 | 11699197 | CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia. | Leuk Lymphoma | 2001 | https://conductscience.org/library/papers/11699197 | PubMed |
| 4 | 8603004 | Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. | Br J Haematol | 1996 | https://conductscience.org/library/papers/8603004 | PubMed |
| 5 | 7237385 | A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. | Cancer | 1981 | https://conductscience.org/library/papers/7237385 | PubMed |
| 6 | 18324964 | Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients. | Br J Haematol | 2008 | https://conductscience.org/library/papers/18324964 | PubMed |
| 7 | 24289109 | Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia. | Leuk Lymphoma | 2014 | https://conductscience.org/library/papers/24289109 | PubMed |
| 8 | 23347903 | Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria. | Leuk Res | 2013 | https://conductscience.org/library/papers/23347903 | PubMed |
| 9 | 16418492 | Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia. | J Clin Oncol | 2006 | https://conductscience.org/library/papers/16418492 | PubMed |
| 10 | 9708202 | Levels of expression of CD19 and CD20 in chronic B cell leukaemias. | J Clin Pathol | 1998 | https://conductscience.org/library/papers/9708202 | PubMed |
| 11 | 31262519 | Immunomodulation of human CD19+CD25high regulatory B cells via Th17/Foxp3 regulatory T cells and Th1/Th2 cytokines. | Hum Immunol | 2019 | https://conductscience.org/library/papers/31262519 | PubMed |
| 12 | 20872890 | Variables affecting the quantitation of CD22 in neoplastic B cells. | Cytometry B Clin Cytom | 2011 | https://conductscience.org/library/papers/20872890 | PubMed |
| 13 | 29450641 | Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation. | Cancer Immunol Immunother | 2018 | https://conductscience.org/library/papers/29450641 | PubMed |
| 14 | 26848054 | The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience. | Br J Haematol | 2016 | https://conductscience.org/library/papers/26848054 | PubMed |
| 15 | 11554173 | Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in B-cell chronic lymphocytic leukemia. | Am J Clin Pathol | 2001 | https://conductscience.org/library/papers/11554173 | PubMed |
| 16 | 3925551 | Localization of the gene encoding the human interleukin-2 receptor on chromosome 10. | Science | 1985 | https://conductscience.org/library/papers/3925551 | PubMed |
| 17 | 28187524 | Phenotypic Characterization of Trisomy 12 Monoclonal B-Cell Lymphocytosis. | Cytometry B Clin Cytom | 2018 | https://conductscience.org/library/papers/28187524 | PubMed |
| 18 | 11136261 | Genomic aberrations and survival in chronic lymphocytic leukemia. | N Engl J Med | 2000 | https://conductscience.org/library/papers/11136261 | PubMed |
| 19 | 11840283 | Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities. | Leukemia | 2002 | https://conductscience.org/library/papers/11840283 | PubMed |
| 20 | 17380198 | Structure and enzymatic functions of human CD38. | Mol Med | 2006 | https://conductscience.org/library/papers/17380198 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42814327 | Clinical Flow Cytometric Testing in Chronic Lymphocytic Leukemia. | Methods Mol Biol | 2027 | https://conductscience.org/library/papers/42814327 |
Source PubMed
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33734005
GET https://conductscience.org/api/papers/v1/33734005/references?page=2